By KAI ICHINO/ Staff Writer
December 23, 2021 at 18:59 JST
Aducanumab, a drug for Alzheimer’s disease jointly developed by Eisai Co. and Biogen Inc. (Provided by Biogen Inc.)
A health ministry expert panel deferred approving the use of aducanumab as a treatment for Alzheimer's-type dementia, citing a need for more data on the drug’s efficacy through a clinical trial that will take years. [Read More]
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.